Appendix E - National Coverage Determinations Manual / Blood-Derived Products for Chronic Non-Healing Wounds 270.3

Why This Topic Matters

Coverage determinations shape whether services and related products are considered payable under Medicare. Understanding this policy helps organizations align documentation, billing, and medical necessity review with the applicable national coverage rules.

Article Sections

1. A. General

   Provides background on wound healing and introduces the broad categories of blood-derived products discussed in the policy. It also frames the clinical settings and wound types addressed by the determination.

2. B. Nationally Covered Indications

   States the covered-indications section and indicates how the policy treats nationally covered use cases.

3. C. Nationally Non-Covered Indications

   Summarizes the non-covered portions of the determination across multiple effective dates. This section also references the policy’s treatment of related evidence and Medicare coverage status over time.

4. D. Other

   Describes the special provision for routine costs associated with qualifying clinical trials and notes the manual reference used for that coverage context.